The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life

Abstract

RM is a useful approach in breast cancer surgery, with a low rate of re-excision and mastectomy. Overall survival at 10 years is similar to that associated with tumorectomy, though with a higher rate of local recurrence. Patient satisfaction and quality of life appears to be good one year after radiotherapy.

Extreme oncoplasty: The last opportunity for breast conservation—Analysis of its impact on survival and quality of life

“…Describing the experience of the Milan European Institute of Oncology, Lorenzi et al reported the incidence of local relapse to be 6.7% at 10 years. Finally, Acea et al found a local relapse incidence of 4.7% and 9.8% at 5 and 10 years, respectively. In these three studies, no difference in overall survival was observed between lumpectomy and oncoplastic procedures.…”

Current practice and short-term outcomes of therapeutic mammaplasty in the international TeaM multicentre prospective cohort study

“…TM procedures are more complex than standard BCS, with potential resource implications. Although complication rates and oncological safety have been reported in the literature the majority of published studies are retrospective, single‐centre, often single‐surgeon case series with limited follow‐up. Many are poorly designed and reported, with inconsistent end‐points that limit cross‐study comparison and meaningful data synthesis.…”

Response to letter to the editor: “Reduction Mammoplasty: Potential for Overtreatment?”

“…We appreciate Dr. Mona Tan's comments about our manuscript 1 and we would like to respond to the different issues raised in her reply. We agree with Dr. Tan that RM can-not be considered the standard technique for the surgical management of breast cancer.…”